NCT00478387View on ClinicalTrials.gov

Ovarian Cancer and Immune Response to Flu Vaccine

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Ovarian Cancer
Interventions
BIOLOGICAL

The current season's trivalent killed influenza vaccine

Trial Locations (1)

19104

Department of Obstetrics and Gynecology, Division of GYN Oncology, Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Pennsylvania

OTHER

NCT00478387 - Ovarian Cancer and Immune Response to Flu Vaccine | Biotech Hunter | Biotech Hunter